Skip to main content
PMC home page
Gut logoLink to Gut
. 1989 Jul;30(7):899–905. doi: 10.1136/gut.30.7.899

Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus.

P D James 1, M Atkinson 1
PMCID: PMC1434272  PMID: 2759487

Abstract

DNA image cytometry was performed on Feulgen stained sections from 91 biopsies obtained during prospective endoscopic surveillance of 55 patients with Barrett's oesophagus. Aneuploid cells were detected in specimens from six of these patients. Four subsequently developed dysplasia and adenocarcinoma but, in the other two, biopsies had been reported as showing specialised epithelium only, with no apparent dysplasia and no evidence of malignancy on clinical follow up to date. In two of the four patients who subsequently developed carcinoma, aneuploid cells were only found in biopsies showing overt dysplasia or carcinoma but in the two other patients aneuploid cells were present in biopsies taken early in the clinical course before any dysplasia had been identified on the original reports. The presence of aneuploid cells on cytometry of these 'benign' biopsies allowed us, on histological review, to identify areas of atypia which were interpreted as mild dysplasia. In this series aneuploidy was always associated with some morphological abnormality varying from mild dysplasia to frank carcinoma. Aneuploid cells were not shown in material from one patient who had an oesophagectomy for dysplasia or in biopsy material from four patients showing 'indefinite dysplasia'. DNA cytometry combines an objective assessment of epithelial atypia with the advantage of detecting rare cellular aneuploidy and the ability to correlate these events with morphology. It should assist in the more accurate diagnosis of dysplasia and prove useful in identifying those patients with Barrett's oesophagus who are at greater risk of subsequently developing malignancy.

Full text

PDF
904

Images in this article

900Fig. 1
on p.900
901Fig. 3
on p.901
902Fig. 4
on p.902

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achkar E., Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol. 1988 Mar;83(3):291–294. [PubMed] [Google Scholar]
  2. Ahnen D. J. Flow cytometric analysis of deoxyribonucleic acid content in the gastrointestinal tract. Is aneuploidy more than a new ploy? Gastroenterology. 1987 Jul;93(1):197–199. doi: 10.1016/0016-5085(87)90334-9. [DOI] [PubMed] [Google Scholar]
  3. BARRETT N. R. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg. 1950 Oct;38(150):175–182. doi: 10.1002/bjs.18003815005. [DOI] [PubMed] [Google Scholar]
  4. Ballantyne K. C., James P. D., Robins R. A., Baldwin R. W., Hardcastle J. D. Flow cytometric analysis of the DNA content of gastric cancer. Br J Cancer. 1987 Jul;56(1):52–54. doi: 10.1038/bjc.1987.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Borrie J., Goldwater L. Columnar cell-lined esophagus: assessment of etiology and treatment. A 22 year experience. J Thorac Cardiovasc Surg. 1976 Jun;71(6):825–834. [PubMed] [Google Scholar]
  6. Böcking A., Adler C. P., Common H. H., Hilgarth M., Granzen B., Auffermann W. Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol. 1984 Mar;6(1):1–8. [PubMed] [Google Scholar]
  7. Cameron A. J., Ott B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985 Oct 3;313(14):857–859. doi: 10.1056/NEJM198510033131404. [DOI] [PubMed] [Google Scholar]
  8. Cooper B. T., Barbezat G. O. Barrett's oesophagus: a clinical study of 52 patients. Q J Med. 1987 Feb;62(238):97–108. [PubMed] [Google Scholar]
  9. Cornelisse C. J., Van Driel-Kulker A. M. DNA image cytometry on machine-selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry. Cytometry. 1985 Sep;6(5):471–477. doi: 10.1002/cyto.990060512. [DOI] [PubMed] [Google Scholar]
  10. Cuvelier C. A., Morson B. C., Roels H. J. The DNA content in cancer and dysplasia in chronic ulcerative colitis. Histopathology. 1987 Sep;11(9):927–939. doi: 10.1111/j.1365-2559.1987.tb01899.x. [DOI] [PubMed] [Google Scholar]
  11. Haggitt R. C., Reid B. J., Rabinovitch P. S., Rubin C. E. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol. 1988 Apr;131(1):53–61. [PMC free article] [PubMed] [Google Scholar]
  12. Hamilton S. R., Smith R. R. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol. 1987 Mar;87(3):301–312. doi: 10.1093/ajcp/87.3.301. [DOI] [PubMed] [Google Scholar]
  13. Jass J. R. Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study. J Clin Pathol. 1981 Aug;34(8):866–870. doi: 10.1136/jcp.34.8.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lee R. G. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Am J Surg Pathol. 1985 Dec;9(12):845–852. doi: 10.1097/00000478-198512000-00001. [DOI] [PubMed] [Google Scholar]
  15. Mays R. G. The Feulgen hydrolysis profiles of [corrected] a metastatic lung tumour in lymph node and a primary breast carcinoma. Med Lab Sci. 1987 Oct;44(4):307–311. [PubMed] [Google Scholar]
  16. McKinley M. J., Budman D. R., Grueneberg D., Bronzo R. L., Weissman G. S., Kahn E. DNA content in Barrett's esophagus and esophageal malignancy. Am J Gastroenterol. 1987 Oct;82(10):1012–1015. [PubMed] [Google Scholar]
  17. Naef A. P., Savary M., Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg. 1975 Nov;70(5):826–835. [PubMed] [Google Scholar]
  18. Paull A., Trier J. S., Dalton M. D., Camp R. C., Loeb P., Goyal R. K. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976 Aug 26;295(9):476–480. doi: 10.1056/NEJM197608262950904. [DOI] [PubMed] [Google Scholar]
  19. Peuchmaur M., Potet F., Goldfain D. Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): a prospective biopsy study. J Clin Pathol. 1984 Jun;37(6):607–610. doi: 10.1136/jcp.37.6.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reid B. J., Haggitt R. C., Rubin C. E., Rabinovitch P. S. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology. 1987 Jul;93(1):1–11. [PubMed] [Google Scholar]
  21. Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Nov;14(11):931–968. doi: 10.1016/s0046-8177(83)80175-0. [DOI] [PubMed] [Google Scholar]
  22. Robertson C. S., Mayberry J. F., Nicholson D. A., James P. D., Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg. 1988 Aug;75(8):760–763. doi: 10.1002/bjs.1800750813. [DOI] [PubMed] [Google Scholar]
  23. Rothery G. A., Patterson J. E., Stoddard C. J., Day D. W. Histological and histochemical changes in the columnar lined (Barrett's) oesophagus. Gut. 1986 Sep;27(9):1062–1068. doi: 10.1136/gut.27.9.1062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rubio C. A., Kato Y. DNA profiles in mitotic cells from gastric adenomas. Am J Pathol. 1988 Mar;130(3):485–488. [PMC free article] [PubMed] [Google Scholar]
  25. Skinner D. B., Walther B. C., Riddell R. H., Schmidt H., Iascone C., DeMeester T. R. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg. 1983 Oct;198(4):554–565. doi: 10.1097/00000658-198310000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spechler S. J., Goyal R. K. Barrett's esophagus. N Engl J Med. 1986 Aug 7;315(6):362–371. doi: 10.1056/NEJM198608073150605. [DOI] [PubMed] [Google Scholar]
  27. Spechler S. J., Robbins A. H., Rubins H. B., Vincent M. E., Heeren T., Doos W. G., Colton T., Schimmel E. M. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 1984 Oct;87(4):927–933. [PubMed] [Google Scholar]
  28. Walle A. J., Niedermayer W. Aneuploidy as a marker of minimal residual disease in leukemia. Cancer Detect Prev. 1985;8(1-2):303–315. [PubMed] [Google Scholar]
  29. Winters C., Jr, Spurling T. J., Chobanian S. J., Curtis D. J., Esposito R. L., Hacker J. F., 3rd, Johnson D. A., Cruess D. F., Cotelingam J. D., Gurney M. S. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987 Jan;92(1):118–124. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES